tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Developments and Strategic Advancements Propel Aura Biosciences Inc’s Buy Rating
PremiumRatingsPromising Developments and Strategic Advancements Propel Aura Biosciences Inc’s Buy Rating
2M ago
Aura Biosciences Advances in Cancer Therapy Trials
Premium
Company Announcements
Aura Biosciences Advances in Cancer Therapy Trials
2M ago
Aura Biosciences Raises $69.9 Million in Public Offering
Premium
Company Announcements
Aura Biosciences Raises $69.9 Million in Public Offering
2M ago
Aura Biosciences: Revised Bel-Sar Model and Strong Financials Support Buy Rating
PremiumRatingsAura Biosciences: Revised Bel-Sar Model and Strong Financials Support Buy Rating
4M ago
Aura Biosciences Expands Board with New Director Appointment
Premium
Company Announcements
Aura Biosciences Expands Board with New Director Appointment
4M ago
Aura Biosciences appoints Bitetti to board of directors
Premium
The Fly
Aura Biosciences appoints Bitetti to board of directors
4M ago
Aura Biosciences price target raised to $25 from $22 at H.C. Wainwright
PremiumThe FlyAura Biosciences price target raised to $25 from $22 at H.C. Wainwright
4M ago
Promising Clinical Data and Abscopal Effect Drive Buy Rating for Aura Biosciences Inc.
Premium
Ratings
Promising Clinical Data and Abscopal Effect Drive Buy Rating for Aura Biosciences Inc.
4M ago
Promising Phase 1 Results for Aura Biosciences’ Bel-sar in Bladder Cancer Boost Buy Rating
Premium
Ratings
Promising Phase 1 Results for Aura Biosciences’ Bel-sar in Bladder Cancer Boost Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100